MedTrace Logo

Vapocoolant Spray to Reduce Pain With Nexplanon Insertion

NCT06933381 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-01-09

No results posted yet for this study

Summary

The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.

Conditions

  • Reducing Pain With Nexplanon Implant Insertion

Interventions

DEVICE

Vapocoolant spray

Pain Ease will be used per manufacturer instruction, applying the spray for 5 seconds or until the skin turns white, whichever occurs first.

OTHER

Placebo

Nature's Tears will be applied to the arm as a placebo spray

Sponsors & Collaborators

  • Lakshmi Devi and Devraj Sharma Endowment

    collaborator UNKNOWN

  • Queen's Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2026-04-01
Completion
2026-05-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06933381 on ClinicalTrials.gov